ADMA Biologics ADMA Plasma Collection Centers — D&A

Other segment segments

Similar metrics at other companies

HAEPlasma products and services — D&A

$11.53M-4.4%

HAEPlasma — D&A

$11.84M-1.9%

HAEBlood Center products and services — D&A

$1.77M-17.5%

HAEBlood Center — D&A

$1.79M-28.9%

GLXYData Centers — D&A

$0-100%

RSMetals Service Centers — D&A

$69.2M+0.7%

Questions, answered.

What is ADMA Biologics's plasma collection centers — D&A?

ADMA Biologics (ADMA) reported plasma collection centers — D&A of $565K in Q1 2026.

How has ADMA Biologics's plasma collection centers — D&A changed year-over-year?

ADMA Biologics's plasma collection centers — D&A decreased by 30.1% year-over-year, from $808K to $565K.

What is the long-term trend for ADMA Biologics's plasma collection centers — D&A?

Over 3 years (2021 to 2024), ADMA Biologics's plasma collection centers — D&A has grown at a 23.7% compound annual growth rate (CAGR), from $1.27M to $2.41M.

What does plasma collection centers — D&A mean?

Represents the systematic allocation of the cost of tangible assets, such as collection equipment and facilities, and intangible assets over their useful lives. This non-cash expense reflects the capital intensity of maintaining a network of plasma centers. It is a key component in calculating the segment's cash flow generation.